Syneron Medical (ELOS) Reports In-Line Q3 EPS

Syneron Medical (NASDAQ: ELOS) reported Q3 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $62.1 million versus the consensus estimate of $66.6 million.

For earnings history and earnings-related data on Syneron Medical (ELOS) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight